ClinicalTrials.Veeva

Menu

Echocardiographic Evaluation of Hypertensive Acute Pulmonary Edema

C

Carol Davila University of Medicine and Pharmacy

Status

Completed

Conditions

Hypertension
Pulmonary Edema

Study type

Observational

Funder types

Other

Identifiers

NCT00829855
ID_216/PNII_242_2007
IDEI_242_2007

Details and patient eligibility

About

Acute cardiogenic pulmonary edema (ACPE), one of the most severe forms of acute heart failure, represents 5% of hospital admissions. One of the most frequent phenomena encountered during ACPE is hypertensive crisis (hypertensive ACPE) but the mechanisms and causes of hypertensive ACPE are insufficiently understood. Few studies have evaluated the cardiac function during hypertensive ACPE, and these studies used only conventional echocardiography methods. New methods of evaluation of cardiac function in hypertensive ACPE (such as Tissue Doppler imaging) have not been used.

The objectives of this study are to evaluate presence and role of the following potential mechanisms of hypertensive ACPE: 1. acute myocardial dysfunction (systolic and diastolic); 2. silent transient myocardial ischemia; 3. acute mechanical left ventricular dyssynchrony; 4. dynamic mitral regurgitation; 5. inter-ventricular interaction. Conventional and Tissue Doppler echocardiography will be used to assess cardiac function.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute onset of dyspnea within the preceding 8 hours
  • respiratory distress and pulmonary rales at any level
  • pulmonary congestion confirmed by chest radiography
  • systolic blood pressure > 160 mmHg before treatment
  • sinus rhythm
  • signed informed consent

Exclusion criteria

  • acute myocardial infarction confirmed by myocardial necrosis markers (either CKMB or troponin I). Angina pectoris alone will not be excluded
  • significant left sided valvular disease (more than moderate). Mitral regurgitation of any severity will not be excluded, due to the hypothesis of the role of dynamic mitral regurgitation in the pathogenesis of acute hypertensive pulmonary edema
  • congenital heart disease
  • cardiac tamponade
  • rhythm and conduction disturbances that may have precipitated pulmonary edema, like sustained ventricular tachycardia and complete heart block

Trial design

51 participants in 2 patient groups

1
Description:
Patients with hypertensive (systolic blood pressure ≥160 mmHg) acute pulmonary edema, evaluated within 120 minutes after admittance.
2
Description:
The same patients from group 1 followed-up at 48 to 96 hours.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems